The Federal Register

Agency Information Collection Activities: Proposed Collection; Comment Request

Tue, Dec 12 2006 11:00:00 GMT

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) allow the proposed information collection project: ``Pilot Study of Proposed Nursing Home Survey on Resident Safety''. In accordance with the Paperwork Reduction Act of 1995, Public Law 10413 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection.

Agency Information Collection Activities: Proposed Collection; Comment Request

Tue, Dec 12 2006 11:00:00 GMT

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) allow the proposed information collection project: ``Development of an Electronic System for Reporting Medication Errors and Adverse Drug Events in Primary Care Practice (MEADERS).'' In accordance with the Paperwork Reduction Act of 1995, Public Law 10413 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection.

Agency Forms Undergoing Paperwork Reduction Act Review

Tue, Dec 12 2006 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 6395960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 3956974. Written comments should be received within 30 days of this notice. Proposed Project

Emergency Epidemic Investigations (09200008)RevisionOffice of Workforce and Career Development (OWCD), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

One of the objectives of CDC's epidemic services is to provide for the prevention and control of epidemics and protect the population from public health crises such as man made or natural biological disasters and chem

Agency Forms Undergoing Paperwork Reduction Act Review

Tue, Dec 12 2006 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 6394766 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 3956974. Written comments should be received within 30 days of this notice. Proposed Project

Information Network (REACH IN)ExtensionNational Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

Racial and Ethnic Approaches to Community Health 2010 (REACH 2010) currently funds forty local coalitions to establish community based programs and culturally appropriate interventions to eliminate racia

Proposed Data Collections Submitted for Public Comment and Recommendations

Tue, Dec 12 2006 11:00:00 GMT

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 4046395960 and send comments to Seleda Perryman, CDC Assistant Reports Clearance [[Page 74541]]
Officer, 1600 Clifton Road, MSD74, Atlanta, GA 30333 or send an email to omb@cdc.gov.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information t

Proposed Data Collections Submitted for Public Comment and Recommendations

Tue, Dec 12 2006 11:00:00 GMT

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 4046395960 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MSD74, Atlanta, GA 30333 or send an email to omb@cdc.gov.

New Animal Drugs For Use in Animal Feeds; Tylosin

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for an alternate feeding regimen for tylosin phosphate in Type C medicated swine feeds used for the control of swine proliferative enteropathies.

Over-the-Counter Human Drugs; Labeling Requirements; Proposed Rule

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is proposing to amend its final rule that established standardized format and content requirements for the labeling of overthecounter (OTC) drug products (Drug Facts Rule, codified at 21 CFR 201.66). This amendment proposes a definition and the option of alternative labeling requirements for ``conveniencesize'' OTC drug packages.

Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee; Amendment of Notice

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee. This meeting was originally announced in the Federal Register of November 24, 2006 (71 FR 67879). The amendment is being made to reflect a change in the Date and Time portion of the document, specifically, a change in the start time of the meeting. There are no other changes.

Health Professions Preparatory, Health Professions Pregraduate and Indian Health Professions Scholarship Programs;

Tue, Dec 12 2006 11:00:00 GMT

Key Dates: Application Deadline: February 28, 2007; Application Review: March 2630, 2007; Application Notification: First week of July, 2007; Award Start Date: August 1, 2007.

I. Funding Opportunity Description

The Indian Health Service (IHS) is committed to encouraging American Indians and Alaska Natives to enter the health professions and to assuring the availability of Indian health professionals to serve Indians. The IHS is committed to the recruitment of students for the following programs:

The Indian Health Professions Preparatory Scholarships authorized by section 103 of the Indian Health Care Improvement Act (IHCIA), as amended.

The Indian Health Professions Pregraduate Scholarships authorized by section 103 of the IHCIA, as amended.

The Indian Health Professions Scholarships authorized by section 104 of the IHCIA, as amended.

Fulltime and parttime scholarships will be funded for each of the three scholarship programs.
II. Award Informatio

Government-Owned Inventions; Availability for Licensing

Tue, Dec 12 2006 11:00:00 GMT

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
[[Page 74547]]

Government-Owned Inventions; Availability for Licensing

Tue, Dec 12 2006 11:00:00 GMT

Government-Owned Inventions; Availability for Licensing

Tue, Dec 12 2006 11:00:00 GMT

National Library of Medicine; Notice of Meeting

Tue, Dec 12 2006 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The portions of the meeting devoted to the review and evaluation of journals for potential indexing by the National Library of Medicine will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended. Premature disclosure of the titles of the journals as potential titles to be indexed by the National Library of Medicine, the discussions, and the presence of individuals associated with these publications could significantly frustrate the review and evaluation of individual j

National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Availability of

Tue, Dec 12 2006 11:00:00 GMT

The CERHR announces the availability of the draft expert panel report for bisphenol A on December 15, 2006, from the CERHR Web site (http://cerhr.niehs.nih.gov) or in printed text from CERHR (see FOR FURTHER INFORMATION CONTACT below). The CERHR invites the submission of public comments on sections 14 of the draft expert panel report (see SUPPLEMENTARY INFORMATION below). The expert panel will meet on March 57, 2007, at the Radisson Hotel Old Town in Alexandria, Virginia to review and revise the draft expert panel report and reach conclusions regarding whether exposure to bisphenol A is a hazard to human development or reproduction. The expert panel will also identify data gaps and research needs. CERHR expert panel meetings are open to the public with time scheduled for oral public comment. Attendance is limited only by the available meeting room space. Following the exp

National Toxicology Program (NTP), NTP Interagency Center for the Evaluation of Alternative Toxicological Methods

Tue, Dec 12 2006 11:00:00 GMT

NICEATM in collaboration with the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) announces an independent scientific peer review meeting to evaluate the validation status of five in vitro pyrogenicity test methods: (1) Human PBMC/IL6 in vitro pyrogen test (PBMC/IL6), (2) human whole blood/IL1 in vitro pyrogen test (WB/IL1), (3) human whole blood/IL1 in vitro pyrogen test: application of cryopreserved human whole blood (cryo WB/ IL1), (4) the human whole blood/IL6 in vitro pyrogen test (WB/IL6), and (5) an alternative in vitro pyrogen test using the human monocytoid cell line MONO MAC6 (MM6/IL6). These five in vitro test methods are proposed as replacements for the in vivo rabbit pyrogen test (RPT). At this meeting, a scientific panel will peer review the draft background review document (BRD) on each test method, evaluate the extent that the BRD addresses established validation and acceptance criteria for each test method, and provide comment on draft ICCVAM